- US12545912utility2026Crispr/cas-related Methods and Compositions for Treating Usher Syndrome and Retinitis Pigmentosa0 cites
- US12460231utility2025Crispr/cas-related Methods and Compositions for Treating Primary Open Angle Glaucoma0 cites
- US12359223utility2025Systems and Methods for Modulating Chromosomal Rearrangements0 cites
- US12338436utility2025Synthetic Guide Molecules, Compositions and Methods Relating Thereto0 cites
- US12331328utility2025Crispr/cas9-mediated Exon-skipping Approach for Ush2a-associated Usher Syndrome0 cites
- US12325854utility2025Crispr-cpf1-related Methods, Compositions and Components for Cancer Immunotherapy0 cites
- US12297466utility2025Engineered Cas9 Nucleases0 cites
- US12286727utility2025Assessing Nuclease Cleavage0 cites
- US12264331utility2025Systems and Methods for One-shot Guide RNA (ogrna) Targeting of Endogenous and Source DNA0 cites
- US12234449utility2025Crispr/cas-related Methods and Compositions for Treating Leber's Congenital Amaurosis 10 (LCA10)0 cites
- US12201699utility2025Compositions and Methods for Promoting Homology Directed Repair0 cites
- US12110545utility2024Methods of Assessing Nuclease Cleavage0 cites
- US12049651utility2024Cas9 Fusion Molecules, Gene Editing Systems, and Methods of Use Thereof0 cites
- US12031132utility2024Systems and Methods for the Treatment of Hemoglobinopathies0 cites
- US11963982utility2024Crispr/rna-guided Nuclease Systems and Methods0 cites
- US11952408utility2024Hpv-specific Binding Molecules0 cites
- US11911415utility2024Crispr/cas-related Methods and Compositions for Improving Transplantation0 cites
- US11851690utility2023Systems and Methods for the Treatment of Hemoglobinopathies0 cites
- US11834649utility2023Crispr/cas-related Methods and Compositions for Treating Herpes Simplex Virus0 cites
Page 1 of 2Next →